More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$310227865
EPS
-1.89
P/E ratio
--
Price to sales
0.19
Dividend yield
--
Beta
1.604569
Previous close
$10.60
Today's open
$10.51
Day's range
$10.09 - $10.58
52 week range
$3.18 - $10.74
show more
CEO
Taryn R. Owen
Employees
4200
Headquarters
Tacoma, WA
Exchange
New York Stock Exchange
Shares outstanding
30444344
Issue type
Common Stock
Industrials
Corporate Services
TrueBlue Q2 Earnings Call Highlights
TrueBlue NYSE: TBI reported second-quarter revenue growth that exceeded its outlook, driven by continued strength in skilled labor verticals and a return to growth in its on-demand business.
MarketBeat • Aug 9, 2026

Despite Fast-paced Momentum, TrueBlue (TBI) Is Still a Bargain Stock
TrueBlue (TBI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research • Aug 7, 2026

TrueBlue, Inc. (TBI) Q2 2026 Earnings Call Transcript
TrueBlue, Inc. (TBI) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 5, 2026

TrueBlue Reports Second Quarter 2026 Results
TACOMA, Wa.--(BUSINESS WIRE)--TrueBlue (NYSE:TBI) today announced its second quarter results for 2026. Second Quarter 2026 Financial Highlights Revenue of $443 million, up 12 percent compared to the prior year period Net loss of $3.4 million compared to net loss of $0.2 million in the prior year period Includes a non-cash loss of $3 million on assets held-for-sale SG&A expense improved 7 percent to $84 million compared to $90 million in the prior year period Adjusted EBITDA1 improved to $11.
Business Wire • Aug 4, 2026

TrueBlue (TBI) Beats Q2 Earnings and Revenue Estimates
TrueBlue (TBI) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.1 per share. This compares to a loss of $0.07 per share a year ago.
Zacks Investment Research • Aug 5, 2026

TrueBlue to Announce Second Quarter 2026 Results
TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue (NYSE: TBI) will release second quarter 2026 earnings results after the market close on Tuesday, Aug. 4, 2026. Management will discuss the results on a webcast at 2:00 p.m. PT (5:00 p.m. ET) on Tuesday, Aug. 4, 2026. The webcast and a presentation of financial information will be available on TrueBlue's website: www.trueblue.com. An audio replay will be available on the Company's website for a period of six months following the call. About TrueBlue TrueB.
Business Wire • Jul 21, 2026

TrueBlue Survey Finds Experienced Workers Are Driving New Interest in Skilled Trades
TACOMA, Wash.--(BUSINESS WIRE)--As construction season accelerates and employers continue to compete for skilled talent, new TrueBlue (NYSE: TBI) survey findings show growing interest in skilled trades among temporary workers, while also pointing to the need for clearer, more affordable pathways into these careers. According to a recent survey of more than 1,200 TrueBlue temporary workers, nearly half of those responding to questions about skilled trades (48%) report greater interest compared t.
Business Wire • Jul 20, 2026

TrueBlue's PeopleReady Named to Selling Power's 2026 List of “60 Best Companies to Sell For”
TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue (NYSE: TBI), a leading provider of specialized workforce solutions, today announced that its flagship brand, PeopleReady, has been named to Selling Power magazine's “60 Best Companies to Sell For” 2026 list. The annual recognition highlights companies that demonstrate strong performance in supporting, developing, and empowering sales organizations. PeopleReady specializes in quick and reliable access to on-demand labor and skilled workers across industri.
Business Wire • Jul 13, 2026

Hope Biosciences Reports Positive Published Clinical Data Following Stem Cell Therapy in Chronic Traumatic Brain Injury
HOUSTON--(BUSINESS WIRE)-- #biopharma--For millions of people living with the long-term effects of traumatic brain injury (TBI), the prevailing belief has been that chronic neuroinflammation causes recovery to plateau over time, meaning correspondingly few long-range care options. New research published in the prestigious journal Brain, one of the world's leading neurology journals, is challenging that assumption. “Our findings suggest that chronic neuroinflammation may be a treatable target, even years aft.
Business Wire • Jun 23, 2026

TrueBlue Earns Forbes Recognition for Temporary Staffing Excellence
TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue (NYSE: TBI), a leading provider of specialized workforce solutions, today announced that two of its staffing brands, PeopleReady and Staff Management | SMX, have been recognized on Forbes' annual list of America's Best Temporary Staffing Firms. The recognition reflects the strength of TrueBlue's differentiated staffing capabilities across on-demand, skilled, and comprehensive workforce management solutions. TrueBlue was recognized through the strong perf.
Business Wire • Jun 10, 2026

¹ Disclosures

Open an M1 investment account to buy and sell TrueBlue Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.